Andrea S. Blevins Primeau, PhD, MBA

Blood type may influence response to immune checkpoint inhibitor therapy among patients with metastatic cancer, a study suggests.

Adding pertuzumab to adjuvant chemotherapy and trastuzumab can improve long-term outcomes in operable, HER2+ early breast cancer, data suggest.

Disparities in cancer diagnoses among pediatric patients are partly a result of disparities in health insurance coverage, a study suggests.

Childbirth is associated with an increased risk of triple-negative breast cancer that persist over time, a large study suggests.

Acupuncture was associated with improvements in symptoms and quality of life.

Researchers sought to determine whether adding rituximab to axicabtagene ciloleucel would have efficacy in patients with refractory large B-cell lymphoma.

Researchers sought to determine the impact of body changes on pediatric patients who undergo treatment for AML.

The findings contradict results from the phase 3 BEACON study.

Researchers sought to determine whether tisagenlecleucel would be safe and effective in patients with primary central nervous system lymphoma.

Medicaid beneficiaries had a higher risk of death than commercially-insured patients, but the risk of death decreased if Medicaid beneficiaries underwent biomarker testing.